Preclinical therapeutic efficacy of the ciprofloxacin‐eluting sinus stent for Pseudomonas aeruginosa sinusitis

Background The ciprofloxacin-eluting sinus stent (CSS) has unique therapeutic potential to deliver antibiotics to the sinuses. The objective of this study is to evaluate the efficacy of the CSS in eliminating Pseudomonas aeruginosa infection in a rabbit model of sinusitis.